#VisualAbstract: Sentinel-node biopsy only is noninferior to completion of axillary lymph node dissection in breast cancer with sentinel-node metastases

1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion axillary lymph node dissection was non-significant (0.89) and below the noninferiority margin. 2. The overall survival rates at 5 years were similar between both groups, 92.9% vs 92%. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous studies have challenged the necessity

Related Keywords

,Minute Medicine Inc ,Rating Level ,Axillary Dissection ,Sentinel Node ,Lymph Node Metastasis ,Axillary Lymph Node Dissection ,Breast Cancer ,Cancer ,Completion Axillary Lymph Node Dissection ,Lymph Node ,Sentinel Lymph Node Biopsy ,Studygraphics ,